High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo

Area of Science:

• Virology
• Immunology
• Infectious Diseases

Background:

• Parvovirus 4 (PARV4) is a recently identified human virus associated with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections.
• T cells play a critical role in viral control and pathogenesis, but their interaction with PARV4 remains uncharacterized.
• Understanding PARV4's impact on the cellular immune system is crucial, especially in individuals exposed to blood-borne viruses.

Purpose of the Study:

• To investigate the presence and nature of T cell responses to Parvovirus 4 (PARV4) in individuals with existing blood-borne viral infections.
• To determine if PARV4 infection elicits detectable cellular immune reactions in the context of HCV and HIV.

Main Methods:

• Utilized Interferon-gamma (IFN-γ) enzyme-linked immunospot assays and intracellular cytokine staining to detect T cell responses.
• Employed tetrameric HLA-A*0201-peptide complexes to define specific lymphocyte populations targeting PARV4 NS peptides.
• Assessed antibody responses using a newly developed PARV4 enzyme-linked immunosorbent assay in 88 HCV-positive and 13 HIV-positive individuals.

Main Results:

• Detected high-frequency T cell responses against multiple PARV4 NS peptides in 26% of the study cohort.
• Observed significant antibody responses to PARV4 in the same individuals.
• Characterized typical T cell responses exceeding 1000 spot-forming units/million peripheral blood mononuclear cells.

Conclusions:

• PARV4 infection is prevalent in individuals exposed to blood-borne viruses, demonstrating strong T cell immunity akin to persistent infections like cytomegalovirus.
• The persistence of PARV4 viral antigen and the associated T cell response may play a role in disease pathogenesis.
• Highlights the significance of cellular immunity in managing PARV4 and its potential contribution to comorbidities in HCV and HIV patients.